Das S K, Biswas Atanu, Roy Trishit, Banerjee T K, Mukherjee C S, Raut D K, Chaudhuri Arijit
Department of Neuromedicine, Bangur Institute of Neurology, Kolkata, India.
Indian J Med Res. 2006 Aug;124(2):163-72.
BACKGROUND & OBJECTIVES: Large scale epidemiological studies on neurological disorders are very few in India. We therefore planned to conduct a cross-sectional population-based epidemiological study on a stratified randomly selected sample from the city of Kolkata to study the prevalence of major neurological disorders such as epilepsy, stroke, dementia and Parkinsonism.
The method of case ascertainment was two- stage house-to-house survey; the first stage was undertaken by a field team consisting of four field workers and a neuropsychologist. Screening questionnaire based on National Institute of Mental Health and Neuro Sciences (NIMHANS) protocol was used. In the second stage a neurologist examined all the screened positive cases.
A total of 52,377 subjects participated in the study. The crude prevalence rates (per 100,000 population) of major neurological disorders with 95 per cent confidence intervals (95% CI) and age adjusted rates (AAR) based on US 2000 population were 557.5 (95% CI 496.17-624.40 and AAR - 516.77) in epilepsy, 486.85 (95% CI 377.0 to 551.11 and AAR-765.68) in stroke, 87.82 (95% CI 64.02-117.50 and AAR-168.4) in dementia and 45.82 (95% CI 29.64-67.63 and AAR-71.64) in Parkinsonism. The weighted prevalence rates (per 100,000) of the whole population based on re-screening of 10 per cent of negative samples were 763.89 (95% CI 690.55- 842.57) in epilepsy, 624.32 (95% CI 555.64-699.24) in stroke and 139.37 (95% CI 108.71-176.06) in dementia.
INTERPRETATION & CONCLUSION: A high rate of stroke and overall lower prevalence of Parkinsonism and dementia was recorded as compared to western studies. High prevalence rate of stroke emphasizes the need to study incidence, morbidity and mortality profile of stroke including its socio-economic impact and also case-control analysis to determine the underlying risk factors.
印度针对神经系统疾病的大规模流行病学研究非常少。因此,我们计划对从加尔各答市分层随机抽取的样本进行一项基于人群的横断面流行病学研究,以调查癫痫、中风、痴呆和帕金森症等主要神经系统疾病的患病率。
病例确诊方法为两阶段逐户调查;第一阶段由一个由四名现场工作人员和一名神经心理学家组成的现场团队进行。使用了基于国家心理健康和神经科学研究所(NIMHANS)方案的筛查问卷。在第二阶段,由一名神经科医生对所有筛查呈阳性的病例进行检查。
共有52377名受试者参与了该研究。癫痫的主要神经系统疾病的粗患病率(每10万人)及其95%置信区间(95%CI)以及基于美国2000年人口的年龄调整率(AAR)分别为557.5(95%CI 496.17 - 624.40,AAR - 516.77);中风为486.85(95%CI 377.0至551.11,AAR - 765.68);痴呆为87.82(95%CI 64.02 - 117.50,AAR - 168.4);帕金森症为45.82(95%CI 29.64 - 67.63,AAR - 71.64)。基于对10%阴性样本重新筛查的整个人口加权患病率(每10万),癫痫为763.89(95%CI 690.55 - 842.57),中风为624.32(95%CI 555.64 - 699.24),痴呆为139.37(95%CI 108.71 - 176.06)。
与西方研究相比,中风患病率较高,而帕金森症和痴呆的总体患病率较低。中风的高患病率强调了有必要研究中风的发病率、发病率和死亡率情况,包括其社会经济影响,以及进行病例对照分析以确定潜在危险因素。